Are Medical Stocks Lagging Adagene (ADAG) This Year?

Company Performance - Adagene Inc. Sponsored ADR (ADAG) has shown a year-to-date performance increase of approximately 60.5%, significantly outperforming the Medical sector's average return of 10.5% [2] - The Zacks Consensus Estimate for ADAG's full-year earnings has risen by 8.9% over the past quarter, indicating improving analyst sentiment and a positive earnings outlook [2] - Adagene Inc. is currently ranked 2 (Buy) in the Zacks Rank system, which is a stock-picking model based on earnings estimates and revisions [1] Industry Comparison - Adagene Inc. is part of the Medical - Biomedical and Genetics industry, which consists of 497 companies and is currently ranked 82 in the Zacks Industry Rank. This industry has seen a year-to-date gain of about 0.6% [3] - In contrast, DaVita HealthCare (DVA), another stock in the Medical sector, belongs to the Medical - Outpatient and Home Healthcare industry, which has a ranking of 45 and has increased by 15.7% year-to-date [3] - Both Adagene Inc. and DaVita HealthCare are noted for their solid performance, suggesting that they are worth monitoring for investors interested in Medical stocks [3]